Welcome to LookChem.com Sign In|Join Free
  • or
(2-phenyl-[1,3]dioxolan-2-yl)-acetonitrile is a chemical compound characterized by a unique structure that combines a phenyl group, a dioxolane ring, and an acetonitrile moiety. The phenyl group is attached to the dioxolane ring, which itself is a five-membered ring containing two oxygen atoms, creating a stable and electron-rich environment. The acetonitrile group, consisting of an acetone unit with a cyano group (-CN), adds a polar and electronegative character to the molecule. This combination results in a compound with potential applications in various chemical and pharmaceutical processes, such as intermediates in the synthesis of more complex molecules or as a building block in the development of new drugs. The specific properties and reactivity of (2-phenyl-[1,3]dioxolan-2-yl)-acetonitrile make it an interesting candidate for further exploration in organic chemistry and related fields.

5738-30-7

Post Buying Request

5738-30-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5738-30-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5738-30-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,3 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5738-30:
(6*5)+(5*7)+(4*3)+(3*8)+(2*3)+(1*0)=107
107 % 10 = 7
So 5738-30-7 is a valid CAS Registry Number.

5738-30-7Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS CONTAINING A PYRROLOPYRIDINE OR BENZIMIDAZOLE CORE

-

Page/Page column 77, (2011/06/26)

The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5 and n are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE

-

Page/Page column 93, (2011/06/26)

Disclosed are novel compounds which inhibit RSK, methods of making such compounds and pharmaceutical compositions comprising such compounds. Also disclosed are methods of treating RSK2 regulated disorders using compounds of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5738-30-7